Drivers influencing the governance of inter-firm relationships in the biopharmaceutical industry: an empirical survey in the Italian context

被引:7
作者
Billitteri, Carolina [1 ]
Lo Nigro, Giovanna [1 ]
Perrone, Giovanni [1 ]
机构
[1] Univ Palermo, DTMPIG, I-90128 Palermo, Italy
关键词
biopharmaceutical industry; inter-firm relationship; governance form; survey; RESEARCH-AND-DEVELOPMENT; TRANSACTION-COST; COMPLEMENTARY ASSETS; STRATEGIC ALLIANCES; ORGANIZATIONAL GOVERNANCE; INCUMBENTS ADVANTAGE; DRUG DEVELOPMENT; DECISION-MAKING; UNCERTAINTY; FIRM;
D O I
10.1080/09537325.2012.751010
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
This paper focuses on factors influencing the choice of the governance form in inter-firm relationships (IFRs) between pharmaceutical and biotechnology companies. By reviewing the relevant literature on transaction cost economics, property right theory, real option and resources-based view, we located some drivers that might influence such relationships and we formulated a set of hypotheses linking them to governance forms. Such a theoretical framework has been empirically tested through a survey conducted among the Italian companies associated to Farmindustria. Empirical results provide some interesting insights on how shaping bio-pharmaceutical deals; we found that the developmental stage of the product/technology object of the agreement, the existence of previous collaborations between firms and the number of products marketed by the biotech company are able to influence the selection of a specific governance form.
引用
收藏
页码:107 / 126
页数:20
相关论文
共 62 条
[1]   Four scenarios for the future of the pharmaceutical industry [J].
Bradfield, Ron ;
El-Sayed, Hany .
TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2009, 21 (02) :195-212
[2]   Technological innovation in the pharmaceutical industry: The use of organizational control in managing research and development [J].
Cardinal, LB .
ORGANIZATION SCIENCE, 2001, 12 (01) :19-36
[3]   Governance structures in strategic alliances: transaction cost versus resource-based perspective [J].
Chen, HM ;
Chen, TJ .
JOURNAL OF WORLD BUSINESS, 2003, 38 (01) :1-14
[4]   Network of collaborations for innovation: The case of biotechnology [J].
Chiesa, V ;
Toletti, G .
TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2004, 16 (01) :73-96
[5]   ABSORPTIVE-CAPACITY - A NEW PERSPECTIVE ON LEARNING AND INNOVATION [J].
COHEN, WM ;
LEVINTHAL, DA .
ADMINISTRATIVE SCIENCE QUARTERLY, 1990, 35 (01) :128-152
[6]  
Contractor F.J., 2002, Journal of International Management, V8, P11, DOI DOI 10.1016/S1075-4253(01)00052-7
[7]   Mergers and Acquisitions in the Pharmaceutical and Biotech Industries [J].
Danzon, Patricia M. ;
Epstein, Andrew ;
Nicholson, Sean .
MANAGERIAL AND DECISION ECONOMICS, 2007, 28 (4-5) :307-328
[8]   A resource-based theory of strategic alliances [J].
Das, TK ;
Teng, BS .
JOURNAL OF MANAGEMENT, 2000, 26 (01) :31-61
[9]   A systematic assessment of the empirical support for transaction cost economics [J].
David, RJ ;
Han, SK .
STRATEGIC MANAGEMENT JOURNAL, 2004, 25 (01) :39-58
[10]   Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms [J].
Deeds, DL ;
DeCarolis, D ;
Coombs, J .
JOURNAL OF BUSINESS VENTURING, 2000, 15 (03) :211-229